This multi-site study assesses the impact of text message reminders on the receipt ofCOVID-19 and influenza text message reminders takes place primarily in practices from theAmerican Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS)network.
The study is to be conducted over the 1st season (September 2024-April 2025) as an
effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This
protocol covers the first season. Parents of eligible children who are 6 month-17
year-old who are due for both a COVID-19 and influenza vaccine will be sent text
messages. Within each practice site, parents of eligible children will be randomized to
receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2)
COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care).
Randomization is to be stratified by practice site, age group and prior year's
COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the
research team.
Behavioral: Text message influenza vaccine reminders
Text message influenza vaccine reminders
Behavioral: Text message COVID-19 vaccine reminders
Text message COVID-19 vaccine reminders
Behavioral: Text message influenza and COVID-19 vaccine reminders
Text message influenza and COVID-19 vaccine reminders
Inclusion Criteria:
- Child that:
- is 6 months-17 year-old children
- due for both a COVID-19 and influenza vaccine
- Receives care at study site
- Language listed in electronic health record is English or Spanish
- Has not opted out of text messages from practice
Exclusion Criteria:
- Has opted out of text messages from practice
- Language listed in electronic health record is not English or Spanish
American Academy of Pediatrics
Itasca, Illinois, United States
Columbia University Irving Medical Center
New York, New York, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States